Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy (Q31925061)

5 July 2017

1 reference

title

Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy (English)

1 reference

5 July 2017

Holsboer F

1

1 reference

5 July 2017

1 January 2001

1 reference

Journal of Affective Disorders

5 July 2017

1 reference

5 July 2017

62

1 reference

5 July 2017

77-91

1 reference

5 July 2017

1-2

1 reference

Brain corticosteroid receptor balance in health and disease

5 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Human corticotropin-releasing hormone in depression--correlation with thyrotropin secretion following thyrotropin-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment--neurobiological and psychometric assessment of course.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Corticosteroid receptor function is decreased in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Treatment of major depression with metyrapone and hydrocortisone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900352-9

7 January 2021

10.1016/S0165-0327(00)00352-9

Identifiers

DOI

1 reference

5 July 2017

1 reference

PubMed ID

11172875